Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Machine, Furnitures, Fixtures & Other Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Receivables Refunds Shares Issued Shares Outstanding Shares Outstanding

Ratios

Wave Life Sciences (WVE) Long-Term Debt Repayments (2016 - 2018)

Wave Life Sciences filings provide 4 years of Long-Term Debt Repayments readings, the most recent being $16000.0 for Q1 2018.

On a quarterly basis, Long-Term Debt Repayments changed 0.0% to $16000.0 in Q1 2018 year-over-year; TTM through Dec 2018 was $16000.0, a 74.19% decrease, with the full-year FY2018 number at $16000.0, down 74.19% from a year prior.
Long-Term Debt Repayments hit $16000.0 in Q1 2018 for Wave Life Sciences, up from $15000.0 in the prior quarter.
In the past five years, Long-Term Debt Repayments ranged from a high of $16000.0 in Q1 2016 to a low of $14000.0 in Q4 2015.
Median Long-Term Debt Repayments over the past 4 years was $15000.0 (2015), compared with a mean of $15363.6.
Biggest five-year swings in Long-Term Debt Repayments: grew 7.14% in 2016 and later changed 0.0% in 2017.
Wave Life Sciences' Long-Term Debt Repayments stood at $14000.0 in 2015, then grew by 7.14% to $15000.0 in 2016, then changed by 0.0% to $15000.0 in 2017, then grew by 6.67% to $16000.0 in 2018.
The last three reported values for Long-Term Debt Repayments were $16000.0 (Q1 2018), $15000.0 (Q4 2017), and $16000.0 (Q3 2017) per Business Quant data.